ATE86632T1 - N-polyosyl-polypeptide. - Google Patents

N-polyosyl-polypeptide.

Info

Publication number
ATE86632T1
ATE86632T1 AT89401421T AT89401421T ATE86632T1 AT E86632 T1 ATE86632 T1 AT E86632T1 AT 89401421 T AT89401421 T AT 89401421T AT 89401421 T AT89401421 T AT 89401421T AT E86632 T1 ATE86632 T1 AT E86632T1
Authority
AT
Austria
Prior art keywords
oside
polyosyl
polypeptides
radical
polypeptide
Prior art date
Application number
AT89401421T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Jean Choay
Maurice Petitou
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Application granted granted Critical
Publication of ATE86632T1 publication Critical patent/ATE86632T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polyamides (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT89401421T 1988-05-24 1989-05-24 N-polyosyl-polypeptide. ATE86632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8806892A FR2631970B1 (fr) 1988-05-24 1988-05-24 N-polyosyl-polypeptides
EP89401421A EP0344068B1 (de) 1988-05-24 1989-05-24 N-Polyosyl-Polypeptide

Publications (1)

Publication Number Publication Date
ATE86632T1 true ATE86632T1 (de) 1993-03-15

Family

ID=9366559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401421T ATE86632T1 (de) 1988-05-24 1989-05-24 N-polyosyl-polypeptide.

Country Status (6)

Country Link
EP (1) EP0344068B1 (de)
JP (1) JPH02238879A (de)
AT (1) ATE86632T1 (de)
DE (1) DE68905239D1 (de)
FR (1) FR2631970B1 (de)
PT (1) PT90655B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン
DE4023556A1 (de) * 1990-07-25 1992-01-30 Goldschmidt Ag Th Haertbare epoxygruppen aufweisende organopolysiloxane, verfahren zu ihrer herstellung und ihre verwendung als haertbare beschichtungsmittel mit abhaesiven eigenschaften
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680524D1 (de) * 1986-04-22 1991-08-29 Valcor Scient Ltd Verfahren zur stabilisierung von proteinen.

Also Published As

Publication number Publication date
PT90655A (pt) 1989-11-30
FR2631970A1 (fr) 1989-12-01
PT90655B (pt) 1994-10-31
JPH02238879A (ja) 1990-09-21
FR2631970B1 (fr) 1993-12-24
EP0344068B1 (de) 1993-03-10
DE68905239D1 (de) 1993-04-15
EP0344068A1 (de) 1989-11-29

Similar Documents

Publication Publication Date Title
Righetti et al. Isoelectric points and molecular weights of proteins: A new table
NO812126L (no) Immunoregulerende diketopiperazinforbindelser og fremgangsmaate til deres fremstilling
NO931996L (no) Haarkondisjoneringsblandinger
ES457050A1 (es) Un procedimiento para la preparacion de aminoacidos cicli- cos.
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
EP0251304A3 (de) Glycosylderivate und ihre Verwendung
EP0163993A3 (de) Struktur und Eigenschaften von modifizierten Interferonen
DK625784A (da) Termoplastisk modificerede epoxysammensaetninger
IT1207992B (it) Derivati glicosilati dell'insulina.
ATE64296T1 (de) Kosmetische zubereitungen mit mandelproteinhydrolysat.
ATE86632T1 (de) N-polyosyl-polypeptide.
IT8521468A0 (it) Procedimento per ottenere interferon leucocitario alfa-2dell'uomo.
EP0128007A3 (de) Phenyltetrahydronaphthylcarboxylat-Derivate
EP0364852A3 (de) Substituierte Glucoside
IT8621280A0 (it) .tipo di punto a sopraggitto nonche' procedimento e dispositivoper la sua produzione.
FI902321A0 (fi) Butensyraderivat.
FR2599430B1 (fr) Pompe d'injection de carburant.
ATE58643T1 (de) Zweiteiliger ski mit verbindungsstueck.
FR2537653B1 (fr) Pompe d'injection de carburant
AR240943A2 (es) Nuevo compuesto agroquimico denominado "sustancia n 51262" procedimiento para prepararlo y composicion que lo comprende"
DE3853065D1 (de) In der Kälte schlagzähe thermoplastische Formmassen.
DK165439C (da) Parenteralt acceptabelt, vandigt praeparat indeholdende dezocin
DE3884484D1 (de) Polyarylenetherketone mit biphenyl-4,4'-dicarbonylgruppen.
FR2530291B1 (fr) Pompe d'injection de carburant
NO901209D0 (no) Stabiliserte polyprenylholdige preparater, deres fremstilling og anvendelse.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties